Profile of bictegravir/emtricitabine/tenofovir alafenamide fixed dose combination and its potential in the treatment of HIV-1 infection: evidence to date
Lucas Hill,1 Shawn R Smith,1 Maile Young Karris2 1University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, San Diego, CA, USA; 2Department of Medicine, University of California San Diego, San Diego, CA, USA Abstract: Modern pharmacologic management of people living w...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-10-01
|
| Series: | HIV/AIDS : Research and Palliative Care |
| Subjects: | |
| Online Access: | https://www.dovepress.com/profile-of-bictegraviremtricitabinetenofovir-alafenamide-fixed-dose-co-peer-reviewed-article-HIV |